BPCE
JAZZ icon

Bank Pictet & Cie (Europe)’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bank Pictet & Cie (Europe)’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,158
Closed -$215K – 145
2020
Q1 		$215K Sell
2,158
-609
-22% -$78.7K 0.02% 136
2019
Q4 		$413K Buy
+2,767
New +$377K 0.06% 119

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank Pictet & Cie (Europe)'s JAZZ Position: Q2 2020 in Review

Bank Pictet & Cie (Europe) sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2020, closing a stake of 2,158 shares — an estimated $215K sold.

Bank Pictet & Cie (Europe) first reported a position in JAZZ in Q4 2019 and held it in 2 quarters. The position peaked at $413K in Q4 2019. 384 funds tracked by Wall St. Rank hold JAZZ as of Q2 2020.

  • Bank Pictet & Cie (Europe) reported no remaining Jazz Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Bank Pictet & Cie (Europe) sold 2,158 Jazz Pharmaceuticals shares in Q2 2020, an estimated $215K.
  • Bank Pictet & Cie (Europe) first reported a position in Jazz Pharmaceuticals in Q4 2019 and held it in 2 quarters.
  • Bank Pictet & Cie (Europe)'s Jazz Pharmaceuticals position peaked at $413K in Q4 2019.
  • 384 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2020.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q2 2020, filed 13 Aug 2020.